Short Interest in Sinopharm Group Co. Ltd. (OTCMKTS:SHTDF) Declines By 13.6%

Sinopharm Group Co. Ltd. (OTCMKTS:SHTDF) was the target of a significant drop in short interest during the month of January. As of January 15th, there was short interest totaling 9,109,332 shares, a drop of 13.6% from the December 31st total of 10,548,049 shares. Based on an average daily volume of 120 shares, the days-to-cover ratio is currently 75,911.1 days. Based on an average daily volume of 120 shares, the days-to-cover ratio is currently 75,911.1 days.

Sinopharm Group Stock Performance

Sinopharm Group stock opened at $2.35 on Tuesday. The stock has a fifty day moving average price of $2.49 and a 200 day moving average price of $2.43. Sinopharm Group has a 52 week low of $2.11 and a 52 week high of $2.60.

About Sinopharm Group

Sinopharm Group Co, Ltd is one of China’s largest state-owned integrated healthcare companies, primarily focused on the research, development, production and distribution of a broad range of pharmaceutical and healthcare products. Established in 1998 through the reorganization of assets under China National Pharmaceutical Group (Sinopharm), the company has grown to encompass multiple business segments, including prescription medicines, over-the-counter drugs, vaccines and medical devices. Sinopharm Group is listed on the Hong Kong Stock Exchange and trades in the United States through its OTCMKTS ticker SHTDF.

The company’s product portfolio spans chemically synthesized drugs, biologics and traditional Chinese medicine formulations, supported by an extensive nationwide manufacturing and quality-control network.